Offstream
news

Changes

1. The European Medicines Agency conditionally approves the use of the Pfizer's anti-COVID-19 oral drug Paxlovid for high-risk adult patients.
   2022-01-29 13:06:06 (First version)
2. The European Medicines Agency conditionally approves the use of the Pfizer anti-COVID-19 oral drug Paxlovid for high-risk adult patients.
   (Current version)

Related